Article

Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension

Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland.
Hypertension (Impact Factor: 7.63). 05/2007; 49(5):981-5. DOI: 10.1161/HYPERTENSIONAHA.107.087338
Source: PubMed

ABSTRACT Cigarette smoking is an important modifiable cardiovascular risk factor and pathophysiological mechanisms may include a stiff vascular tree. Although smokers have stiffer arteries, whether smoking cessation is associated with reduced arterial stiffness is not known. We compared never-treated patients with essential hypertension (n=554) aged 18 to 80 years (56% females) classified as current smokers (n=150), ex-smokers (n=136), and nonsmokers (n=268). Ex-smokers were categorized into <1 year, >1 and <10 years, and >10 years of smoking cessation. Measurements included aortic stiffness, assessed as pulse wave velocity (Complior), wave reflection (augmentation index [AIx]), and transit time (T(R)) (Sphygmocor). Current and ex-smokers had significantly higher pulse wave velocity and AIx compared with nonsmokers (pulse wave velocity for current smokers: 10.7+/-0.2; ex-smokers: 10.6+/-0.2; nonsmokers: 9.9+/-0.1 m/s; P<0.001; AIx for current smokers: 31+/-1; ex-smokers: 30+/-1; nonsmokers: 27+/-0.8%; P<0.05), whereas T(R) was lower in current and ex-smokers compared with nonsmokers (T(R) for current smokers: 131+/-1.0; ex-smokers: 135+/-1; nonsmokers: 137+/-0.8 m/s; P<0.0001). There was a significant linear relationship between smoking status and pulse wave velocity (P<0.001), AIx (P<0.001), and T(R) (P<0.001), even after adjusting for age, sex, mean arterial pressure, heart rate, and body mass index. In ex-smokers, duration of smoking cessation had a significant linear relationship with improvement in pulse wave velocity (P<0.001), AIx (P<0.001), and T(R) (P<0.001), with arterial stiffness parameters returning to nonsignificant levels after a decade of smoking cessation.

Download full-text

Full-text

Available from: Noor Ahmed Jatoi, Aug 19, 2015
1 Follower
 · 
189 Views
  • Source
    • "Smoking causes a very long list of diseases including: heart disease, stroke, impotence lung diseases low birth weight, premature birth and bleeding, miscarriage, sudden infant death syndrome. Second-hand smoking can also produce health problems (Jatoi et al., 2007). Nicotine is eliminated from the body within 48 hours after the last cigarette. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Present piece of study was conducted to evaluate whether hypertension is associated with cigarette smoking in Pakistan. Study started with random screening of the inhabitants of the area for smoking, hypertension and associated risk factors. A self administered questionnaire was prepared for this purpose. Overweight and obesity were assessed by body mass index and hypertension by recording of blood pressure. Amongst the total 3382 selected volunteers, smokers were 933, they had significantly higher systolic blood pressure Mean ± SD 130.1±16.33 mm Hg, CV 12.1 against 127.6±15.19, CV 11.9, diastolic pressure 87.2±11.28 mm Hg, CV 12.9, against 84.8±9.80, CV 11.5. Slightly changes in mean arterial pressure noted in smokers 101.5±6.63, CV 18.4, compared to non smokers, it was 99.1±7.77, C.V 18.2. Smokers also had significantly higher pulse rate 78.6±7.24 compared to 68.8±5.76 beats/minute in non smokers. Smoking had significant correlation with SBP, DBP, MAP and BMI,-.311,-.312,-.313 and. 255 respectively. Similarly, prevalence of hypertension in smokers was higher (23.5%) than in non smokers (16.4%).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Emphysema, a subset of COPD, occurs due to an abnormal inflammatory response to noxious gases or particles leading an influx of immunologic cells. Recent studies have demonstrated endothelial dysfunction in COPD subjects and are suggestive of a vascular phenotype present in COPD that is not fully characterized. We hypothesize that processes affecting the pulmonary vasculature lead to early changes important in the pathogenesis of COPD. This work focuses on the use of multidetector-row computed tomography (MDCT)-based measures of pulmonary blood flow (PBF), mean transit time (MTT) and pulmonary vascular volume (TPVV) to gain new insights into vasculature-related changes present in COPD. As a precursor to using perfusion MDCT imaging to phenotype lung disease, we demonstrated good regional correlation of PBF measurements obtained with MDCT imaging and fluorescent microspheres (FMS) at a FMS piece size resolution of 1.9 cm3 and regional volume level of 8-10 cm3. Additionally, we developed an ex vivo perfusion system, and applied quantitative image analysis techniques to study the lung preparation's stability over 120 minutes. We further validated CT-based PBF and MTT measurements by demonstrating physiologically appropriate responses to a range of flow rates with this new system. Finally, quantitative MDCT-based measurements were used to characterize a novel phenotype of emphysema and test hypotheses regarding vasculature-related changes in smokers and COPD subjects. We demonstrated increased heterogeneity in regional MTT and PBF measurements in smokers with preclinical emphysema compared with smokers with normal lung function and imaging studies and nonsmokers. This data is supportive of the notion that inflammatory-based vascular responses to hypoxia are occurring in smokers susceptible to COPD, but are successfully blocked in smokers without signs of emphysema. A new CT-based measure, TPVV, was studied and we demonstrate its association with total lung volume and body size metrics. TPVV measurements correlated with measures of COPD severity. A trend linking increased TPVV with increased endothelial dysfunction was observed, suggesting that pathological changes of COPD have an effect on the pulmonary vasculature. This work demonstrates the importance of functional information that can compliment structural, anatomical information to answer questions based on the lung physiology and pathological disease processes.
  • Source
Show more